13 citations
,
February 2025 in “Journal of the European Academy of Dermatology and Venereology” Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.
December 2015 in “International Journal of Ayurvedic Medicine” The review lists substances from an ancient text that are good for hair health.
March 2026 in “Journal of Translational Autoimmunity” Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.
7 citations
,
November 2021 in “JAAD Case Reports” Mogamulizumab can cause hair loss and skin rashes.
2 citations
,
June 2013 in “Herba Polonica” The extract from Elephantopus scaber Linn. might help with hair growth in rats.
17 citations
,
January 2015 in “Dermatology online journal” A patient's grey hair regained color during treatment with adalimumab.
26 citations
,
September 2012 in “Cell Reports” B-Raf and C-Raf are essential for maintaining melanocyte stem cells to prevent hair graying.
48 citations
,
June 2000 in “Japanese Journal of Cancer Research” Dimethylarsinic acid speeds up skin tumor growth in certain mice.
4 citations
,
March 2025 in “The Journal of Dermatology” Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.
51 citations
,
December 2006 in “Mammalian Genome” 
July 2022 in “International journal of pharmacognosy and life science” Mangrove plants have many health benefits and help prevent soil erosion and baldness.
9 citations
,
February 2011 in “Revista Brasileira de Farmacognosia” Tridax procumbens plant parts boost immune response in mice.
May 2025 in “Journal of the European Academy of Dermatology and Venereology” Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.
16 citations
,
April 1998 in “Journal of Investigative Dermatology” ACTH promotes hair growth in mink, but α-MSH does not.
1 citations
,
May 2024 in “Pediatric Blood & Cancer” Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.
76 citations
,
January 1998 in “Mammalian Genome” October 2025 in “International Research Journal of Ayurveda & Yoga” The article reviews the role of Kusthadi Lepa in treating Ek-Kustha, which resembles psoriasis, a chronic autoimmune skin condition. Psoriasis is typically managed with synthetic drugs and treatments like methotrexate and steroid creams, but these can have side effects. The article highlights the need for safer, effective treatments and discusses traditional Ayurvedic approaches, specifically Kusthadi Lepa, as mentioned by Acharya Charak. These external treatments, including Takradhara and Udhavartan, are suggested to be effective for managing Ek-Kustha symptoms.
August 2024 in “Advanced Healthcare Materials” RK81 can help promote hair growth.
September 2019 in “International journal of research in ayurveda and pharmacy” Ayurvedic treatment with Bhringraj Vati and coconut oil was safe and effective for reducing hair fall.
2 citations
,
June 2022 in “Journal of Applied Pharmaceutical Science” 4-O-Methylhonokiol from Magnolia shows promise for hair growth, cancer, diabetes, and more, but needs better absorption.
75 citations
,
February 2017 in “Aging” SkQ1 antioxidant improved health and lifespan in mice.
3 citations
,
May 2016 in “International Journal of Research in Ayurveda and Pharmacy” Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.
March 2025 in “Formosa Journal of Sustainable Research” Mangkokan leaf extract at 7% concentration speeds up wound healing.
January 2025 in “RGUHS Journal of Ayush Sciences” Traditional Ayurvedic treatment improved hair loss in a young woman.
16 citations
,
October 2018 in “BMC Complementary and Alternative Medicine” Crataeva nurvala leaves may help reduce anxiety and improve sleep.
December 2025 in “International Journal For Multidisciplinary Research” Premature graying of hair is increasing due to stress, genetics, and pollution.
January 2024 in “American journal of clinical dermatology” Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.
1 citations
,
February 2023 in “Tropical Journal of Pharmaceutical Research” Polysulfonic acid mucopolysaccharide can reduce skin scarring.
December 2025 in “The Journal of Dermatology” Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.
May 2025 in “CPT Pharmacometrics & Systems Pharmacology” A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.